1794 NEW ZEALAND GAZETTE, No. 76

5 MAY 2005

Product:

Tetanus Immunoglobulin
Active Ingredient:
Tetanus immunoglobulin, human 250IU
Dosage Form:
Solution for injection
New Zealand Sponsor:
CSL New Zealand Limited
Manufacturer:
CSL Limited, Broadmeadows, Victoria, Australia

Product:

Zoster Immunoglobulin
Active Ingredient:
Zoster immunoglobulin, human 100IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
CSL New Zealand Limited
Manufacturer:
CSL Limited, Broadmeadows, Victoria, Australia

Dated this 28th day of April 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2672

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is
set out in the Schedule hereto:

Schedule

Product:

Vaxigrip vaccine
Active Ingredients:
Influenza virus A/Wellington/1/2004(H3N2)-like strain 10µg/dose
Influenza virus B/Shanghai/361/2002-like strain 15µg/dose
Influenza virus haemagglutin type A/New Caledonia/20/99 H1N1-like strain 15µg/dose
Dosage Form:
Solution for injection
New Zealand Sponsor:
Aventis Pharma Limited
Manufacturers:
Aventis Pasteur SA, Marcy L’Etoile, France
Aventis Pasteur SA, Val-De-Reuil Cedex, France

Note: This medicine has provisional consent that expires on 31 March 2006.

Dated this 3rd day of May 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2771

Mental Health (Compulsory Assessment and Treatment) Act 1992

Mental Health (Compulsory Assessment and Treatment) Act Notice 2005—Appointment of Directors of Area Mental Health Services

Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Karen Olive Poutasi, Director-General of Health, give the following notice.

Notice

1. This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Act Notice 2000—Appointment of Directors of Area Mental Health Services (“the principal notice”)*.

2. The Schedule to the principal notice is amended in respect of
   “Area 7—Waikato”
   by omitting the name and title
   “Dr Clive Bensemann, medical practitioner of Hamilton”†
   and substituting the name and title
   “Dr Niazi Kraya, consultant psychiatrist, of Waikato.”

Dated at Wellington this 26th day of April 2005.

KAREN O. POUTASI (DR), Director-General of Health.

*New Zealand Gazette, 31 August 2000, page 2963
†New Zealand Gazette, 27 September 2001, page 3384

go2612

New Zealand Public Health and Disability Act 2000

Appointment to the National Advisory Committee on Health and Disability

Pursuant to section 11 of the New Zealand Public Health and Disability Act 2000, I appoint

Phil Shoemack

as a member to the National Advisory Committee on Health and Disability for a three-year term of office commencing from the date of this notification.

Dated at Wellington this 12th day of April 2005.

ANNETTE KING, Minister of Health.

go2593

Advice Notice to General Practitioners Concerning Patient Benefits and Other Subsidies—Amendment No. 4

This variation amendment No. 4 is made to the Advice Notice to General Practitioners under section 88 of the New Zealand Public Health and Disability Act 2000 (originally issued 1 May 2000 under section 51 of the Health and Disability Services Act 1993) and with the approval of the Minister of Health.